- Home
- SDSTW vs INM Comparison
SDSTW vs INM Comparison
Compare SDSTW & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDSTW
- INM
- Stock Information
- Founded
- SDSTW N/A
- INM 1981
- Country
- SDSTW United States
- INM Canada
- Employees
- SDSTW 8
- INM N/A
- Industry
- SDSTW
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- SDSTW
- INM Health Care
- Exchange
- SDSTW Nasdaq
- INM Nasdaq
- Market Cap
- SDSTW 3.4M
- INM 4.1M
- IPO Year
- SDSTW N/A
- INM N/A
- Fundamental
- Price
- SDSTW $0.19
- INM $1.71
- Analyst Decision
- SDSTW
- INM
- Analyst Count
- SDSTW 0
- INM 0
- Target Price
- SDSTW N/A
- INM N/A
- AVG Volume (30 Days)
- SDSTW 41.6K
- INM 64.4K
- Earning Date
- SDSTW 03-26-2025
- INM 11-06-2025
- Dividend Yield
- SDSTW N/A
- INM N/A
- EPS Growth
- SDSTW N/A
- INM N/A
- EPS
- SDSTW N/A
- INM N/A
- Revenue
- SDSTW N/A
- INM $4,798,116.00
- Revenue This Year
- SDSTW N/A
- INM N/A
- Revenue Next Year
- SDSTW N/A
- INM N/A
- P/E Ratio
- SDSTW N/A
- INM N/A
- Revenue Growth
- SDSTW N/A
- INM N/A
- 52 Week Low
- SDSTW $0.10
- INM $1.56
- 52 Week High
- SDSTW $0.12
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- SDSTW 58.29
- INM 36.66
- Support Level
- SDSTW $0.17
- INM $1.56
- Resistance Level
- SDSTW $0.19
- INM $1.92
- Average True Range (ATR)
- SDSTW 0.03
- INM 0.09
- MACD
- SDSTW -0.00
- INM -0.02
- Stochastic Oscillator
- SDSTW 32.94
- INM 32.76
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.